Stephen Fodor, Jami Nachtsheim 

Affymetrix Founder and Chairman Stephen Fodor is retiring from the company's board, effective Jan. 30. Jami Nachtsheim will succeed Fodor as Chairwoman. 

Fodor founded Affy in 1992 and initially was the company's scientific director. In 1993, he was named the firm's president and served as its CEO from 1997 to 2008. He has been on the board since Affy's founding and became its chairman in 1999.  

Nachtsheim has been an Affy director since 2010. Three years later, she became its lead independent director.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.